AU6497198A - Improved method for the reduction of neointima formation after angioplasty - Google Patents

Improved method for the reduction of neointima formation after angioplasty

Info

Publication number
AU6497198A
AU6497198A AU64971/98A AU6497198A AU6497198A AU 6497198 A AU6497198 A AU 6497198A AU 64971/98 A AU64971/98 A AU 64971/98A AU 6497198 A AU6497198 A AU 6497198A AU 6497198 A AU6497198 A AU 6497198A
Authority
AU
Australia
Prior art keywords
angioplasty
reduction
improved method
neointima formation
neointima
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU64971/98A
Inventor
Ulrich Martin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Roche Diagnostics GmbH
Original Assignee
Boehringer Mannheim GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Mannheim GmbH filed Critical Boehringer Mannheim GmbH
Publication of AU6497198A publication Critical patent/AU6497198A/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2863Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for growth factors, growth regulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU64971/98A 1997-02-14 1998-02-13 Improved method for the reduction of neointima formation after angioplasty Abandoned AU6497198A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP97102365 1997-02-14
PCT/EP1998/000837 WO1998035697A1 (en) 1997-02-14 1998-02-13 Improved method for the reduction of neointima formation after angioplasty

Publications (1)

Publication Number Publication Date
AU6497198A true AU6497198A (en) 1998-09-08

Family

ID=8226473

Family Applications (1)

Application Number Title Priority Date Filing Date
AU64971/98A Abandoned AU6497198A (en) 1997-02-14 1998-02-13 Improved method for the reduction of neointima formation after angioplasty

Country Status (2)

Country Link
AU (1) AU6497198A (en)
WO (1) WO1998035697A1 (en)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0573510T3 (en) * 1991-01-17 1998-04-27 Univ Washington Anti-growth factor antibodies in the treatment of vascular stenosis
DK0686044T3 (en) * 1993-02-25 2000-10-09 Zymogenetics Inc Inhibition of intimal hyperplasia using antibodies against PDGF receptors
US5605696A (en) * 1995-03-30 1997-02-25 Advanced Cardiovascular Systems, Inc. Drug loaded polymeric material and method of manufacture
US5882644A (en) * 1996-03-22 1999-03-16 Protein Design Labs, Inc. Monoclonal antibodies specific for the platelet derived growth factor β receptor and methods of use thereof

Also Published As

Publication number Publication date
WO1998035697A1 (en) 1998-08-20

Similar Documents

Publication Publication Date Title
AU5005700A (en) Method for the manufacture of toothpaste
AU2046297A (en) Method for the manufacture of ammonia
HUP0004946A3 (en) Method for producing triazolinthion derivatives and the novel intermediates
AU2468800A (en) Bumper beam and method of manufacturing the same
AU2964500A (en) Method of micro-fabrication
ZA988455B (en) Method for the synthesis of quinoline derivatives
IL131772A0 (en) Improved method for producing thiazolidinediones
IL119612A0 (en) Method for the production of khalas
AU5737498A (en) Method for the preparation of alpha-bromo-lactam derivatives
AU6132598A (en) Method for generating curves
AU5115600A (en) Impact beam and method of manufacturing the same
AU2387897A (en) Method for the manufacture of brushes
HUP9901029A3 (en) Method for the production of rdspa alfa1
AU6333199A (en) Webbing and method for producing the same
AU9344298A (en) Method of producing substituted 2-nitroguanidine derivatives
AU2430600A (en) Coating agent and method for its production
AU1699700A (en) Method of manufacturing structural members
AU6497198A (en) Improved method for the reduction of neointima formation after angioplasty
AU7652798A (en) Method for continuous production of dihydroxydiphenylalkanes
AUPO870297A0 (en) Method
AUPO937097A0 (en) Method
GB9704499D0 (en) Method of manufacture
AU2488697A (en) Process for the manufacture of acetonylbenzamides
AU1966799A (en) Method for producing chlorobenzoxazolene
AU8212898A (en) Method for producing 2-cyclododecyl-1-propanol